Roche Pharma India launches new digital platform - The Blue Tree 2.0 mobile app
Roche Pharma India partnered with smart tech solutions provider MOURI Tech to develop this patient-centric mobile app.;
Delhi: Roche Pharma India today launched a new digital platform - The Blue Tree 2.0 mobile app for patients who are part of Roche's Blue Tree patient support programme in India. The mobile application, available in both Android and iOS platforms will make it easier for patients to access a variety of patient support services, thus simplifying their treatment journey.
Roche has partnered with Tata 1MG which overall manages The Blue Tree program and the last-mile deliveries are managed by Vardhaman and IMS. The bouquet of services are delivered through various service providers with whom Tata 1MG engages on behalf of the patient. Roche Pharma India partnered with smart tech solutions provider MOURI Tech to develop this patient-centric mobile app.
"The app aims to improve both the patient and healthcare professional's experience by speeding up programme enrollment, providing easy access and advance notifications to avail multiple support services, increasing the scale and reach of the program to patients, particularly to those who are in remote locations, and allows the support programme journey to be managed directly from their phones," the company stated.
Dr. Amit Rauthan, HOD Medical Oncology, Manipal Hospital, Bengaluru, says, "As medical professionals, we look to ensure the best possible treatment outcomes for our patients. Medication alone does not provide these outcomes; they are a combination of medicine, access to disease information, patient monitoring, adherence to treatment schedules, and many other services to provide holistic care to the patient. As a single-point destination, The Blue Tree program will enable accessibility and thereby enhance treatment outcomes as well. It is truly a futuristic endeavor and a boon for the healthcare ecosystem".
In the future, the company plans many feature enhancements for the mobile app, including version extensions for HCPs, hospitals, and distributors.
Read also: Roche, Chugai Pharma to transfer Bonviva business in Japan to Taisho Pharma
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.